| |
| |
|
| Insider
Information: |
Brown Julia R |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
134,315 |
|
|
Indirect Shares
|
6,000 |
|
|
| Direct
Value |
$932,185 |
|
|
|
Indirect Value
|
$3,068 |
|
|
| Total
Shares |
140,315 |
|
|
| Total
Value |
$935,253 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gyre Therapeutics |
GYRE |
Director |
2014-12-11 |
10,000 |
2014-12-11 |
6,000 |
Premium* |
|
|
Cleveland Biolabs Inc |
CBLI |
Director |
2015-01-08 |
116,482 |
2013-06-19 |
0 |
Premium* |
|
|
Albireo Pharma Inc |
ALBO |
Director |
2018-06-07 |
7,833 |
2018-06-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2018-06-07 |
4 |
OE |
$9.00 |
$29,997 |
D/D |
3,333 |
7,833 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Director |
– • – |
2018-06-07 |
4 |
OE |
$17.05 |
$78,960 |
D/D |
4,500 |
4,500 |
0 |
- |
|
| CBLI |
Cleveland Biolabs Inc |
Director |
– • – |
2015-01-08 |
4 |
A |
$0.30 |
$18,750 |
D/D |
62,500 |
116,482 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2014-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| CBLI |
Cleveland Biolabs Inc |
Director |
– • – |
2014-10-01 |
5 |
A |
$9.20 |
$17,508 |
D/D |
1,903 |
2,700 |
0 |
- |
|
| CBLI |
Cleveland Biolabs Inc |
Director |
– • – |
2013-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,939 |
15,939 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2013-05-10 |
4 |
B |
$5.09 |
$30,534 |
I/I |
6,000 |
6,000 |
2.1 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-05-13 |
4 |
S |
$23.38 |
$212,782 |
D/D |
(9,100) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2011-05-13 |
4 |
OE |
$8.70 |
$79,170 |
D/D |
9,100 |
9,100 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-05-21 |
4 |
S |
$23.13 |
$169,018 |
D/D |
(7,307) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-05-21 |
4 |
OE |
$8.70 |
$63,571 |
D/D |
7,307 |
7,307 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-05-20 |
4 |
S |
$22.97 |
$119,278 |
D/D |
(5,193) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-05-20 |
4 |
OE |
$8.70 |
$45,179 |
D/D |
5,193 |
5,193 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2010-05-12 |
4 |
S |
$23.05 |
$172,875 |
D/D |
(7,500) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
Director |
– • – |
2009-03-17 |
4 |
B |
$3.03 |
$22,725 |
D/D |
7,500 |
7,500 |
2.39 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
